Table 2 Comparison of clinical characteristics between the two risk groups.
From: Identification of the molecular subtypes and construction of risk models in neuroblastoma
Data source | Clinical Information | High-risk | Low-risk | P value |
|---|---|---|---|---|
E-MTAB-8248 + GSE120559 | TERT status |  |  | P < 0.001 |
Wild type | 130 | 260 | Â | |
TERT rearrangement | 30 | 9 | Â | |
E-MTAB-8248 + GSE120559 | APBs status |  |  | 0.310 |
Negative | 138 | 222 | Â | |
Positive | 22 | 47 | Â | |
GSE73517 | Chromosomes 1 |  |  | P < 0.001 |
1p deletion | 35 | 9 | Â | |
Others | 18 | 43 | Â | |
GSE73517 | Chromosomes 11 | Â | Â | 0.302 |
11q deletion | 17 | 12 | Â | |
Others | 36 | 40 | Â | |
GSE73517 | Chromosomes 17 |  |  | P < 0.001 |
17q gain | 39 | 13 | Â | |
Others | 14 | 39 | Â |
